APA (7th ed.) Citation

Yamashita, T., Shiota, M., Machidori, A., Kobayashi, S., Matsumoto, T., Monji, K., . . . Eto, M. (2021). Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer. Cancer Investigation, 39(3), 251. https://doi.org/10.1080/07357907.2020.1871486

Chicago Style (17th ed.) Citation

Yamashita, Takuya, et al. "Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer." Cancer Investigation 39, no. 3 (2021): 251. https://doi.org/10.1080/07357907.2020.1871486.

MLA (9th ed.) Citation

Yamashita, Takuya, et al. "Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer." Cancer Investigation, vol. 39, no. 3, 2021, p. 251, https://doi.org/10.1080/07357907.2020.1871486.